Arm shares drop 5% after hours despite Q2 beat as outlook barely tops forecasts

Despite beating on both earnings and revenue, the 5% share decline highlighted the high market expectations, with guidance that only matched consensus disappointing investors. This reaction could weigh on AI-linked chip names during the regular session, as richly valued stocks have little buffer for anything short of a clear upgrade. The AGI CPU order book offers some long-term support, but near-term trading will likely depend on positioning rather than the delivery timeline. A recovery would probably require more definite signs of the new processor's revenue contribution.

---

Earlier:

• Qualcomm topped Q4 expectations but shares fell 2% on light profit guidance

---

Although Arm exceeded every headline metric, an outlook that merely matched expectations failed to satisfy a stock already valued for greater growth.

Summary:

• Adjusted EPS of 52 cents beat the 47-cent forecast, and revenue of about $1.44 billion topped the $1.38 billion estimate.
• Q3 revenue guidance of $1.49 billion to $1.59 billion and adjusted EPS of about 56 cents sit slightly above consensus.
• Annualised contract value of about $1.79 billion was slightly below expectations.
• AGI CPU purchase orders extend through calendar 2027, with first commercial deliveries on track for the fourth quarter.
• Partners shipped over 10 billion Arm-based chips in a quarter for the first time, and Arm-based PCs are about 20% of global PC shipments.
• Shares fell about 5% after hours.

Arm Holdings shares dropped about 5% after hours, despite the chip designer beating fiscal second-quarter forecasts, as investors weighed guidance that only narrowly topped estimates and a slight shortfall in a key licensing measure.

Adjusted EPS reached 52 cents, above the 47-cent analyst estimate, and revenue of roughly $1.44 billion exceeded the approximately $1.38 billion forecast, a beat of just over 4%.

Fiscal third-quarter guidance was near consensus. Arm projects revenue between $1.49 billion and $1.59 billion, with a $1.54 billion midpoint just above the roughly $1.53 billion estimate, and adjusted EPS of about 56 cents versus 55 cents expected. Adjusted operating expenses are forecast around $825 million, largely in line with expectations.

Annualised contract value, a metric for licensing commitments, was about $1.79 billion, slightly under the approximately $1.80 billion forecast. Although the miss was minor, for a stock valued for robust growth, an outlook that only equals estimates leaves narrow margin for disappointment.

The accompanying commentary was more positive. Arm said purchase orders for its AGI CPU data centre processor now extend through calendar 2027, and first commercial deliveries are still on schedule for the fourth quarter. This product represents a shift for a company that has traditionally licensed designs to chipmakers rather than selling its own chips, and the order backlog provides early evidence of customer commitment.

Arm also noted that for the first time, partners shipped over 10 billion Arm-based chips in one quarter, and Arm-based PCs now represent about 20% of global PC shipments, indicating the architecture's expansion beyond its smartphone origins.

The stock price reaction indicates investors expected a larger increase in the outlook than Arm provided. Focus now shifts to whether AGI CPU deliveries occur on time and how quickly the processor adds to revenue, factors that will be key to whether Arm can support its growth valuation into next year.